US 7816087
Gene expressed in prostate cancer and methods of use
granted A61KA61K39/00A61P
Quick answer
US patent 7816087 (Gene expressed in prostate cancer and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K39/00, A61P, A61P35/00